Reprint of “Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
•This EHNS-ESMO-ESTRO Clinical Practice Guideline provides key recommendations for managing SCCHN.•It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.•Opportunities for personalised medicine in SCCHN are also discussed.•All recommendations were compil...
Saved in:
| Published in | Oral oncology Vol. 113; p. 105042 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
01.02.2021
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •This EHNS-ESMO-ESTRO Clinical Practice Guideline provides key recommendations for managing SCCHN.•It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.•Opportunities for personalised medicine in SCCHN are also discussed.•All recommendations were compiled by a multidisciplinary group of experts from different institutions and countries.•Recommendations are based on available clinical evidence and the collective expert opinion of the authors. |
|---|---|
| AbstractList | •This EHNS-ESMO-ESTRO Clinical Practice Guideline provides key recommendations for managing SCCHN.•It covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.•Opportunities for personalised medicine in SCCHN are also discussed.•All recommendations were compiled by a multidisciplinary group of experts from different institutions and countries.•Recommendations are based on available clinical evidence and the collective expert opinion of the authors. |
| ArticleNumber | 105042 |
| Author | Grau, C. Licitra, L. Gregoire, V. Machiels, J.-P. René Leemans, C. Golusinski, W. |
| Author_xml | – sequence: 1 givenname: J.-P. surname: Machiels fullname: Machiels, J.-P. organization: Service d’Oncologie Médicale, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium – sequence: 2 givenname: C. surname: René Leemans fullname: René Leemans, C. organization: Department of Otolaryngology-Head and Neck Surgery, Amsterdam University Medical Centres, Cancer Centre Amsterdam, Vrije Universiteit, Amsterdam, the Netherlands – sequence: 3 givenname: W. surname: Golusinski fullname: Golusinski, W. organization: Department of Head and Neck Surgery, Poznan University of Medical Sciences and The Greater Poland Cancer Centre, Poznan, Poland – sequence: 4 givenname: C. surname: Grau fullname: Grau, C. organization: Department of Oncology and Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark – sequence: 5 givenname: L. surname: Licitra fullname: Licitra, L. organization: Head and Neck Cancer Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy – sequence: 6 givenname: V. surname: Gregoire fullname: Gregoire, V. organization: Department of Radiation Oncology, Centre Léon Bérard, Lyon, France |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33583513$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUctuEzEUtVARffELyGLFIhPsmfE8ukNpaJEKqZp2bTn2deNoxp7aM4Xs-iHwF3xRvwQPaRHLbuz7OPdc-5xDtGedBYTeUzKlhBYfN1PnReOsdI273U5Tko4NRvL0FTqgVVknhNXZXoyzokqqrGT76DCEDSGEUUbeoP0sY1XGaHaAfl9B543tsdP48eHn8m4QrRsCltA0WAovjXWtGLv9GvC4N1bvTb-d4Eb4rf0xiUXXrf_GWFiF19vuOT_B8_Nvy2S-_LqIx_XVAs8aY42MJJdeyN5IwGeDURCrELB2Hisjbq0LJkxw70H0LcS3jbTaNY37ngzd48OvY_RaiybA26f7CN18nl_PzpOLxdmX2aeLRKY16xNarpSuRVUIVbAqZzpPhSgLFkWUVNQVU7WiBJjMikLqtCxTXVPNiohMKWOr7Ah92PF23t0NEHremjAqIyxEkXiaV3VBCM1JhJ7soNK7EDxoHmVtowqcEj66xjf8f9f46BrfuRaH3z3tGVYtqH-jzzZFwOkOAPG39wY8D9KAlaCMB9lz5cxL9vwB2JW1qA |
| CitedBy_id | crossref_primary_10_3390_cancers13092109 crossref_primary_10_3390_healthcare12060652 crossref_primary_10_1371_journal_pone_0293475 crossref_primary_10_3390_cancers13235959 crossref_primary_10_1007_s40336_023_00578_0 crossref_primary_10_3390_healthcare12101014 crossref_primary_10_3892_or_2024_8738 crossref_primary_10_1007_s00405_023_07997_9 crossref_primary_10_1080_13696998_2022_2095826 crossref_primary_10_1002_hed_27450 crossref_primary_10_1080_14737140_2024_2357806 crossref_primary_10_17816_1728_2802_2021_25_3_259_266 crossref_primary_10_3390_cancers15153786 crossref_primary_10_3390_cancers15174232 crossref_primary_10_3892_ol_2023_14170 crossref_primary_10_3390_ncrna9010009 crossref_primary_10_1016_j_oraloncology_2022_106026 crossref_primary_10_3390_cancers15215117 crossref_primary_10_3389_fonc_2022_829761 crossref_primary_10_1016_j_radonc_2022_06_001 |
| Cites_doi | 10.1038/nature14129 10.1056/NEJM199106133242402 10.1158/1078-0432.CCR-14-2481 10.1002/hed.23945 10.1093/annonc/mdx304 10.18632/oncotarget.3301 10.1200/JCO.2020.38.15_suppl.6502 10.1200/JCO.2007.14.8841 10.1056/NEJMoa0802656 10.1016/S0140-6736(18)32779-X 10.1016/j.radonc.2017.10.016 10.1016/j.oraloncology.2018.11.015 10.1016/j.radonc.2011.03.004 10.1093/jnci/djv368 10.1001/jamaoto.2019.1187 10.1200/JCO.2014.55.3925 10.1016/j.humpath.2017.05.014 10.1056/NEJMoa032641 10.1086/321805 10.1200/JCO.2012.44.0164 10.1093/annonc/mdx299 10.1056/NEJMoa071028 10.1016/j.ijrobp.2017.02.218 10.1016/j.ejca.2019.08.026 10.1016/S1470-2045(13)70011-1 10.1016/j.ejca.2016.08.013 10.1016/S0140-6736(19)32591-7 10.1200/JCO.18.00684 10.1016/S1470-2045(19)30410-3 10.1186/s40425-019-0662-5 10.1093/annonc/mdy060 10.1158/1078-0432.CCR-16-0323 10.1093/jnci/88.13.890 10.2967/jnumed.113.136796 10.1016/j.anl.2018.08.015 10.1016/j.radonc.2009.04.014 10.1002/cncr.23442 10.1016/0360-3016(93)90167-T 10.1016/j.radonc.2015.10.014 10.3322/caac.21492 10.1016/j.otorri.2018.11.003 10.1016/j.oraloncology.2018.09.020 10.1016/S0140-6736(18)31999-8 10.1016/j.radonc.2009.01.005 10.1200/JCO.2013.53.5633 10.1097/MOO.0b013e32833782f0 10.1001/jamaoncol.2017.0973 10.1093/annonc/mdt461 10.1016/j.clon.2011.11.001 10.1016/j.radonc.2019.01.018 10.1016/S1470-2045(17)30458-8 10.1056/NEJMoa070956 10.1016/S1535-6108(04)00112-6 10.1016/j.radonc.2013.10.010 10.1002/hed.25858 10.1177/0194599819860808 10.1056/NEJMoa053422 10.1200/JCO.2019.37.15_suppl.6002 10.1186/s40463-016-0142-6 10.1093/annonc/mdx310 10.1016/j.ejca.2015.08.023 10.1016/S0360-3016(01)01690-X 10.1016/S1470-2045(17)30445-X 10.1016/j.radonc.2008.03.008 10.1038/nrc.2018.11 10.1056/NEJMoa032646 10.1056/NEJMoa1506007 10.1200/JCO.2013.54.6309 10.1093/annonc/mdx222 10.1016/j.radonc.2011.05.036 10.1016/S1470-2045(11)70346-1 10.1093/annonc/mdy160 10.1200/JCO.2004.08.021 10.1056/NEJMoa1602252 10.1056/NEJMoa1514493 10.1200/JCO.2017.76.2591 10.3389/fonc.2019.00293 10.1056/NEJMoa0912217 10.3389/fonc.2019.00086 10.1200/JCO.2017.74.9457 10.1016/S0140-6736(18)32752-1 10.1200/JCO.2012.43.6097 |
| ContentType | Journal Article |
| Copyright | 2020 Elsevier Ltd |
| Copyright_xml | – notice: 2020 Elsevier Ltd |
| CorporateAuthor | on behalf of the EHNS Executive Board, ESMO Guidelines Committee, ESTRO Executive Board EHNS Executive Board, ESMO Guidelines Committee, ESTRO Executive Board |
| CorporateAuthor_xml | – name: on behalf of the EHNS Executive Board, ESMO Guidelines Committee, ESTRO Executive Board – name: EHNS Executive Board, ESMO Guidelines Committee, ESTRO Executive Board |
| DBID | NPM AAYXX CITATION 7X8 |
| DOI | 10.1016/j.oraloncology.2020.105042 |
| DatabaseName | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Dentistry |
| EISSN | 1879-0593 |
| EndPage | 105042 |
| ExternalDocumentID | 10_1016_j_oraloncology_2020_105042 33583513 S1368837520304784 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29N 3O- 4.4 457 4CK 4G. 53G 5RE 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAWTL AAXUO ABBQC ABFNM ABJNI ABLJU ABLVK ABMAC ABMZM ABOCM ABXDB ABYKQ ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B LCYCR M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K X7M XPP Z5R ZA5 ZGI ~G- AAXKI AFJKZ AKRWK NPM AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c295t-17bdf9a86ad65845f42aa765101c1a985d9d10e5c366cf2772f91f5645f2155b3 |
| IEDL.DBID | AIKHN |
| ISSN | 1368-8375 |
| IngestDate | Fri Aug 16 23:29:01 EDT 2024 Thu Sep 26 17:41:01 EDT 2024 Sat Sep 28 08:23:12 EDT 2024 Fri Feb 23 02:45:22 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | SCCHN Treatment Diagnosis Clinical Practice Guidelines Follow-up |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c295t-17bdf9a86ad65845f42aa765101c1a985d9d10e5c366cf2772f91f5645f2155b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 33583513 |
| PQID | 2489600140 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | proquest_miscellaneous_2489600140 crossref_primary_10_1016_j_oraloncology_2020_105042 pubmed_primary_33583513 elsevier_sciencedirect_doi_10_1016_j_oraloncology_2020_105042 |
| PublicationCentury | 2000 |
| PublicationDate | February 2021 2021-02-00 20210201 |
| PublicationDateYYYYMMDD | 2021-02-01 |
| PublicationDate_xml | – month: 02 year: 2021 text: February 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Oral oncology |
| PublicationTitleAlternate | Oral Oncol |
| PublicationYear | 2021 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Lefebvre, Chevalier, Luboinski (b0265) 1996; 88 Saleh, Daste, Martin (b0380) 2019; 121 Wong, Shah (b0180) 2010; 18 Haddad, O'Neill, Rabinowits (b0305) 2013; 14 Posner, Hershock, Blajman (b0280) 2007; 357 Leeman, Li, Pei (b0360) 2017; 3 Lacas, Bourhis, Overgaard (b0165) 2017; 18 Mazeron, Ardiet, Haie-Méder (b0175) 2009; 91 Peters, Goepfert, Ang (b0320) 1993; 26 Wong, Sonoda, Gharpurhy (b0035) 2012; 24 Marth, Landoni, Mahner (b0415) 2018; 29 Liao, Hsu, Wang (b0150) 2016; 38 Fu, Foreman, Goldstein (b0350) 2016; 45 Cherny, Dafni, Bogaerts (b0420) 2017; 28 Biau, Lapeyre, Troussier (b0110) 2019; 134 Ferris, Blumenschein, Fayette (b0385) 2016; 375 Cohen, Bell, Bifulco (b0065) 2019; 7 Nauta, Rietbergen, van Bokhoven (b0050) 2018; 29 Imbimbo, Alfieri, Botta (b0405) 2019; 161 Marcus, Ciarallo, Tahari (b0315) 2014; 55 Mehanna, Wong, McConkey (b0040) 2016; 374 Janoray, Pointreau, Garaud (b0285) 2016; 108 De Cecco, Nicolau, Giannoccaro (b0090) 2015; 6 O'Sullivan, Huang, Siu (b0250) 2013; 31 Nichols, Theurer, Prisman (b0135) 2019; 20 Bernier, Domenge, Ozsahin (b0330) 2004; 350 Ghi, Paccagnella, Ferrari (b0295) 2017; 28 Vermorken, Herbst, Leon (b0395) 2008; 112 Denis, Garaud, Bardet (b0220) 2004; 22 Bonner, Harari, Giralt (b0225) 2006; 354 Ang, Trotti, Brown (b0345) 2001; 51 El-Naggar, Chan, Takata, Grandis, Slootweg (b0045) 2017; 66 Blanchard, Baujat, Holostenco (b0190) 2011; 100 Wolf, Fisher, Hong (b0270) 1991; 324 Kiyota, Tahara, Fujii (b0340) 2020; 38 (b0070) 2015; 517 Szturz, Wouters, Kiyota (b0195) 2019; 9 Schilling, Stoeckli, Haerle (b0155) 2015; 51 Ang, Harris, Wheeler (b0020) 2010; 363 Cadoni, Boccia, Petrelli (b0025) 2012; 32 Keck, Zuo, Khattri (b0085) 2015; 21 Nguyen-Tan, Zhang, Ang (b0205) 2014; 32 Ang, Zhang, Rosenthal (b0240) 2014; 32 Machtay, Moughan, Trotti (b0255) 2008; 26 Gillison, Trotti, Harris (b0235) 2019; 393 Bray, Ferlay, Soerjomataram (b0005) 2018; 68 Zhang, Koneva, Virani (b0095) 2016; 22 O'Sullivan (b0100) 2017 Huang, Hahn, Tsang (b0130) 2018; 86 Mehanna, Robinson, Hartley (b0230) 2019; 393 Cohen, Karrison, Kocherginsky (b0290) 2014; 32 Fakhry, Lacchetti, Rooper (b0055) 2018; 36 Budach, Bölke, Kammers (b0245) 2016; 118 Leemans, Snijders, Brakenhoff (b0075) 2018; 18 Pignon, le Maître, Maillard (b0185) 2009; 92 Moreno, Frank, Garden (b0125) 2019; 88 Cohen, Soulieres, Le Tourneau (b0390) 2019; 393 Spreafico, Huang, Xu (b0200) 2016; 67 Hitt, Grau, López-Pousa (b0300) 2014; 25 Postmus, Kerr, Oudkerk (b0410) 2017; 28 Burtness, Harrington, Greil (b0365) 2019; 394 Forastiere, Zhang, Weber (b0260) 2013; 31 Grégoire, Ang, Budach (b0115) 2014; 110 Kayhan, Koc, Erdim (b0145) 2019; 46 Gatta, Capocaccia, Botta (b0010) 2017; 18 Dykewicz (b0425) 2001; 33 Grégoire, Evans, Le (b0120) 2018; 126 D'Cruz, Vaish, Kapre (b0160) 2015; 373 Bourhis, Sire, Graff (b0215) 2012; 13 Rosenthal, Mohamed, Garden (b0325) 2017; 98 Guigay, Fayette, Mesia (b0375) 2019; 37 Golusiński (b0140) 2019; 9 Torabi, Benchetrit, Kuo (b0105) 2019 Cooper, Pajak, Forastiere (b0335) 2004; 350 Vermorken, Remenar, van Herpen (b0275) 2007; 357 Maghami, Ismaila, Alvarez (b0355) 2020 Noronha, Joshi, Patil (b0210) 2018; 36 Chung, Parker, Karaca (b0080) 2004; 5 Geoffrois, Martin, De Raucourt (b0310) 2018; 36 Vermorken, Mesia, Rivera (b0370) 2008; 359 Rassy, Nicolai, Pavlidis (b0060) 2019; 41 Senft, de Bree, Hoekstra (b0030) 2008; 87 Overgaard (b0170) 2011; 100 León, García, López (b0400) 2020; 71 Taberna, Mena, Pavón (b0015) 2017; 28 33239190 - Ann Oncol. 2020 Nov;31(11):1462-1475 Janoray (10.1016/j.oraloncology.2020.105042_b0285) 2016; 108 Saleh (10.1016/j.oraloncology.2020.105042_b0380) 2019; 121 Bray (10.1016/j.oraloncology.2020.105042_b0005) 2018; 68 Spreafico (10.1016/j.oraloncology.2020.105042_b0200) 2016; 67 Forastiere (10.1016/j.oraloncology.2020.105042_b0260) 2013; 31 Noronha (10.1016/j.oraloncology.2020.105042_b0210) 2018; 36 Cooper (10.1016/j.oraloncology.2020.105042_b0335) 2004; 350 Gatta (10.1016/j.oraloncology.2020.105042_b0010) 2017; 18 Budach (10.1016/j.oraloncology.2020.105042_b0245) 2016; 118 Guigay (10.1016/j.oraloncology.2020.105042_b0375) 2019; 37 Posner (10.1016/j.oraloncology.2020.105042_b0280) 2007; 357 Cohen (10.1016/j.oraloncology.2020.105042_b0290) 2014; 32 Zhang (10.1016/j.oraloncology.2020.105042_b0095) 2016; 22 De Cecco (10.1016/j.oraloncology.2020.105042_b0090) 2015; 6 Maghami (10.1016/j.oraloncology.2020.105042_b0355) 2020 Postmus (10.1016/j.oraloncology.2020.105042_b0410) 2017; 28 Chung (10.1016/j.oraloncology.2020.105042_b0080) 2004; 5 Ang (10.1016/j.oraloncology.2020.105042_b0345) 2001; 51 Vermorken (10.1016/j.oraloncology.2020.105042_b0370) 2008; 359 Grégoire (10.1016/j.oraloncology.2020.105042_b0120) 2018; 126 Cadoni (10.1016/j.oraloncology.2020.105042_b0025) 2012; 32 Schilling (10.1016/j.oraloncology.2020.105042_b0155) 2015; 51 León (10.1016/j.oraloncology.2020.105042_b0400) 2020; 71 Wong (10.1016/j.oraloncology.2020.105042_b0035) 2012; 24 Haddad (10.1016/j.oraloncology.2020.105042_b0305) 2013; 14 Ferris (10.1016/j.oraloncology.2020.105042_b0385) 2016; 375 Dykewicz (10.1016/j.oraloncology.2020.105042_b0425) 2001; 33 Rosenthal (10.1016/j.oraloncology.2020.105042_b0325) 2017; 98 Marcus (10.1016/j.oraloncology.2020.105042_b0315) 2014; 55 Ang (10.1016/j.oraloncology.2020.105042_b0240) 2014; 32 Moreno (10.1016/j.oraloncology.2020.105042_b0125) 2019; 88 Geoffrois (10.1016/j.oraloncology.2020.105042_b0310) 2018; 36 Ang (10.1016/j.oraloncology.2020.105042_b0020) 2010; 363 Biau (10.1016/j.oraloncology.2020.105042_b0110) 2019; 134 Senft (10.1016/j.oraloncology.2020.105042_b0030) 2008; 87 Szturz (10.1016/j.oraloncology.2020.105042_b0195) 2019; 9 Cohen (10.1016/j.oraloncology.2020.105042_b0065) 2019; 7 O'Sullivan (10.1016/j.oraloncology.2020.105042_b0250) 2013; 31 Fu (10.1016/j.oraloncology.2020.105042_b0350) 2016; 45 Huang (10.1016/j.oraloncology.2020.105042_b0130) 2018; 86 Torabi (10.1016/j.oraloncology.2020.105042_b0105) 2019 Mehanna (10.1016/j.oraloncology.2020.105042_b0040) 2016; 374 Vermorken (10.1016/j.oraloncology.2020.105042_b0395) 2008; 112 Keck (10.1016/j.oraloncology.2020.105042_b0085) 2015; 21 Fakhry (10.1016/j.oraloncology.2020.105042_b0055) 2018; 36 Bourhis (10.1016/j.oraloncology.2020.105042_b0215) 2012; 13 Burtness (10.1016/j.oraloncology.2020.105042_b0365) 2019; 394 Leeman (10.1016/j.oraloncology.2020.105042_b0360) 2017; 3 Lacas (10.1016/j.oraloncology.2020.105042_b0165) 2017; 18 Vermorken (10.1016/j.oraloncology.2020.105042_b0275) 2007; 357 Kayhan (10.1016/j.oraloncology.2020.105042_b0145) 2019; 46 (10.1016/j.oraloncology.2020.105042_b0070) 2015; 517 Imbimbo (10.1016/j.oraloncology.2020.105042_b0405) 2019; 161 O'Sullivan (10.1016/j.oraloncology.2020.105042_b0100) 2017 Bonner (10.1016/j.oraloncology.2020.105042_b0225) 2006; 354 Blanchard (10.1016/j.oraloncology.2020.105042_b0190) 2011; 100 Bernier (10.1016/j.oraloncology.2020.105042_b0330) 2004; 350 Nauta (10.1016/j.oraloncology.2020.105042_b0050) 2018; 29 Golusiński (10.1016/j.oraloncology.2020.105042_b0140) 2019; 9 Kiyota (10.1016/j.oraloncology.2020.105042_b0340) 2020; 38 Machtay (10.1016/j.oraloncology.2020.105042_b0255) 2008; 26 Lefebvre (10.1016/j.oraloncology.2020.105042_b0265) 1996; 88 Nichols (10.1016/j.oraloncology.2020.105042_b0135) 2019; 20 Mehanna (10.1016/j.oraloncology.2020.105042_b0230) 2019; 393 Cohen (10.1016/j.oraloncology.2020.105042_b0390) 2019; 393 Peters (10.1016/j.oraloncology.2020.105042_b0320) 1993; 26 Ghi (10.1016/j.oraloncology.2020.105042_b0295) 2017; 28 Liao (10.1016/j.oraloncology.2020.105042_b0150) 2016; 38 Pignon (10.1016/j.oraloncology.2020.105042_b0185) 2009; 92 Hitt (10.1016/j.oraloncology.2020.105042_b0300) 2014; 25 Cherny (10.1016/j.oraloncology.2020.105042_b0420) 2017; 28 Nguyen-Tan (10.1016/j.oraloncology.2020.105042_b0205) 2014; 32 Taberna (10.1016/j.oraloncology.2020.105042_b0015) 2017; 28 Overgaard (10.1016/j.oraloncology.2020.105042_b0170) 2011; 100 Rassy (10.1016/j.oraloncology.2020.105042_b0060) 2019; 41 Wong (10.1016/j.oraloncology.2020.105042_b0180) 2010; 18 Marth (10.1016/j.oraloncology.2020.105042_b0415) 2018; 29 El-Naggar (10.1016/j.oraloncology.2020.105042_b0045) 2017; 66 Grégoire (10.1016/j.oraloncology.2020.105042_b0115) 2014; 110 Wolf (10.1016/j.oraloncology.2020.105042_b0270) 1991; 324 Leemans (10.1016/j.oraloncology.2020.105042_b0075) 2018; 18 D'Cruz (10.1016/j.oraloncology.2020.105042_b0160) 2015; 373 Mazeron (10.1016/j.oraloncology.2020.105042_b0175) 2009; 91 Gillison (10.1016/j.oraloncology.2020.105042_b0235) 2019; 393 Denis (10.1016/j.oraloncology.2020.105042_b0220) 2004; 22 |
| References_xml | – volume: 68 start-page: 394 year: 2018 end-page: 424 ident: b0005 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin contributor: fullname: Soerjomataram – volume: 36 start-page: 1064 year: 2018 end-page: 1072 ident: b0210 article-title: Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: A phase III randomized noninferiority trial publication-title: J Clin Oncol contributor: fullname: Patil – volume: 350 start-page: 1937 year: 2004 end-page: 1944 ident: b0335 article-title: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck publication-title: N Engl J Med contributor: fullname: Forastiere – volume: 324 start-page: 1685 year: 1991 end-page: 1690 ident: b0270 article-title: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer publication-title: N Engl J Med contributor: fullname: Hong – volume: 55 start-page: 1411 year: 2014 end-page: 1416 ident: b0315 article-title: Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes publication-title: J Nucl Med contributor: fullname: Tahari – volume: 6 start-page: 9627 year: 2015 end-page: 9642 ident: b0090 article-title: Head and neck cancer subtypes with biological and clinical relevance: meta-analysis of gene-expression data publication-title: Oncotarget contributor: fullname: Giannoccaro – volume: 86 start-page: 171 year: 2018 end-page: 180 ident: b0130 article-title: The interplay of IMRT and transoral surgery in HPV-mediated oropharyngeal cancer: getting the balance right publication-title: Oral Oncol contributor: fullname: Tsang – volume: 24 start-page: 190 year: 2012 end-page: 195 ident: b0035 article-title: 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers–an audit and review of published studies publication-title: Clin Oncol (R Coll Radiol) contributor: fullname: Gharpurhy – volume: 357 start-page: 1705 year: 2007 end-page: 1715 ident: b0280 article-title: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer publication-title: N Engl J Med contributor: fullname: Blajman – volume: 18 start-page: 269 year: 2018 end-page: 282 ident: b0075 article-title: The molecular landscape of head and neck cancer publication-title: Nat Rev Cancer contributor: fullname: Brakenhoff – volume: 393 start-page: 156 year: 2019 end-page: 167 ident: b0390 article-title: Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study publication-title: Lancet contributor: fullname: Le Tourneau – volume: 18 start-page: 79 year: 2010 end-page: 82 ident: b0180 article-title: The role of the head and neck surgeon in contemporary multidisciplinary treatment programs for advanced head and neck cancer publication-title: Curr Opin Otolaryngol Head Neck Surg contributor: fullname: Shah – volume: 375 start-page: 1856 year: 2016 end-page: 1867 ident: b0385 article-title: Nivolumab for recurrent squamous-cell carcinoma of the head and neck publication-title: N Engl J Med contributor: fullname: Fayette – volume: 100 start-page: 33 year: 2011 end-page: 40 ident: b0190 article-title: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site publication-title: Radiother Oncol contributor: fullname: Holostenco – volume: 108 year: 2016 ident: b0285 article-title: Long-term results of a multicenter randomized phase III trial of induction chemotherapy with cisplatin, 5-fluorouracil, +/- docetaxel for larynx preservation publication-title: J Natl Cancer Inst contributor: fullname: Garaud – volume: 32 start-page: 3858 year: 2014 end-page: 3866 ident: b0205 article-title: Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity publication-title: J Clin Oncol contributor: fullname: Ang – volume: 112 start-page: 2710 year: 2008 end-page: 2719 ident: b0395 article-title: Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies publication-title: Cancer contributor: fullname: Leon – volume: 22 start-page: 4735 year: 2016 end-page: 4745 ident: b0095 article-title: Subtypes of HPV-positive head and neck cancers are associated with HPV characteristics, copy number alterations, PIK3CA mutation, and pathway signatures publication-title: Clin Cancer Res contributor: fullname: Virani – volume: 28 start-page: 2206 year: 2017 end-page: 2212 ident: b0295 article-title: Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial publication-title: Ann Oncol contributor: fullname: Ferrari – volume: 3 start-page: 1487 year: 2017 end-page: 1494 ident: b0360 article-title: Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques publication-title: JAMA Oncol contributor: fullname: Pei – volume: 21 start-page: 870 year: 2015 end-page: 881 ident: b0085 article-title: Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes publication-title: Clin Cancer Res contributor: fullname: Khattri – volume: 66 start-page: 10 year: 2017 end-page: 12 ident: b0045 article-title: The fourth edition of the head and neck World Health Organization blue book: editors' perspectives publication-title: Hum Pathol contributor: fullname: Slootweg – volume: 32 start-page: 1 year: 2012 end-page: 11 ident: b0025 article-title: A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism publication-title: Acta Otorhinolaryngol Ital contributor: fullname: Petrelli – volume: 374 start-page: 1444 year: 2016 end-page: 1454 ident: b0040 article-title: PET-CT surveillance versus neck dissection in advanced head and neck cancer publication-title: N Engl J Med contributor: fullname: McConkey – volume: 51 start-page: 2777 year: 2015 end-page: 2784 ident: b0155 article-title: Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer publication-title: Eur J Cancer contributor: fullname: Haerle – volume: 118 start-page: 238 year: 2016 end-page: 243 ident: b0245 article-title: Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials publication-title: Radiother Oncol contributor: fullname: Kammers – volume: 517 start-page: 576 year: 2015 end-page: 582 ident: b0070 article-title: Comprehensive genomic characterization of head and neck squamous cell carcinomas publication-title: Nature – volume: 38 start-page: 6502 year: 2020 ident: b0340 article-title: Phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck (JCOG1008) publication-title: J Clin Oncol contributor: fullname: Fujii – volume: 31 start-page: 543 year: 2013 end-page: 550 ident: b0250 article-title: Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis publication-title: J Clin Oncol contributor: fullname: Siu – volume: 28 start-page: iv1 year: 2017 end-page: iv21 ident: b0410 article-title: Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol contributor: fullname: Oudkerk – volume: 359 start-page: 1116 year: 2008 end-page: 1127 ident: b0370 article-title: Platinum-based chemotherapy plus cetuximab in head and neck cancer publication-title: N Engl J Med contributor: fullname: Rivera – volume: 18 start-page: 1221 year: 2017 end-page: 1237 ident: b0165 article-title: Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis publication-title: Lancet Oncol contributor: fullname: Overgaard – volume: 88 start-page: 66 year: 2019 end-page: 74 ident: b0125 article-title: Intensity modulated proton therapy (IMPT) - the future of IMRT for head and neck cancer publication-title: Oral Oncol contributor: fullname: Garden – volume: 121 start-page: 123 year: 2019 end-page: 129 ident: b0380 article-title: Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck publication-title: Eur J Cancer contributor: fullname: Martin – volume: 26 start-page: 3582 year: 2008 end-page: 3589 ident: b0255 article-title: Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis publication-title: J Clin Oncol contributor: fullname: Trotti – volume: 161 start-page: 635 year: 2019 end-page: 642 ident: b0405 article-title: Surveillance of patients with head and neck cancer with an intensive clinical and radiologic follow-up publication-title: Otolaryngol Head Neck Surg contributor: fullname: Botta – volume: 13 start-page: 145 year: 2012 end-page: 153 ident: b0215 article-title: Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99–02): an open-label phase 3 randomised trial publication-title: Lancet Oncol contributor: fullname: Graff – volume: 110 start-page: 172 year: 2014 end-page: 181 ident: b0115 article-title: Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines publication-title: Radiother Oncol contributor: fullname: Budach – start-page: 17 year: 2017 end-page: 54 ident: b0100 article-title: Head and neck tumours publication-title: UICC TNM classification of malignant tumours contributor: fullname: O'Sullivan – volume: 25 start-page: 216 year: 2014 end-page: 225 ident: b0300 article-title: A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer publication-title: Ann Oncol contributor: fullname: López-Pousa – volume: 28 start-page: 2340 year: 2017 end-page: 2366 ident: b0420 article-title: ESMO-Magnitude of Clinical Benefit Scale version 1.1 publication-title: Ann Oncol contributor: fullname: Bogaerts – volume: 7 start-page: 184 year: 2019 ident: b0065 article-title: The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) publication-title: J ImmunoTher Cancer contributor: fullname: Bifulco – volume: 46 start-page: 285 year: 2019 end-page: 293 ident: b0145 article-title: Oncological outcomes of early glottic carcinoma treated with transoral robotic surgery publication-title: Auris Nasus Larynx contributor: fullname: Erdim – year: 2019 ident: b0105 article-title: Prognostic case volume thresholds in patients with head and neck squamous cell carcinoma publication-title: JAMA Otolaryngol Head Neck Surg contributor: fullname: Kuo – volume: 26 start-page: 3 year: 1993 end-page: 11 ident: b0320 article-title: Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Ang – volume: 394 start-page: 1915 year: 2019 end-page: 1928 ident: b0365 article-title: Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study publication-title: Lancet contributor: fullname: Greil – volume: 126 start-page: 3 year: 2018 end-page: 24 ident: b0120 article-title: Delineation of the primary tumour clinical target volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines publication-title: Radiother Oncol contributor: fullname: Le – volume: 363 start-page: 24 year: 2010 end-page: 35 ident: b0020 article-title: Human papillomavirus and survival of patients with oropharyngeal cancer publication-title: N Engl J Med contributor: fullname: Wheeler – volume: 98 start-page: 1002 year: 2017 end-page: 1011 ident: b0325 article-title: Final report of a prospective randomized trial to evaluate the dose-response relationship for postoperative radiation therapy and pathologic risk groups in patients with head and neck cancer publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Garden – volume: 393 start-page: 51 year: 2019 end-page: 60 ident: b0230 article-title: Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial publication-title: Lancet contributor: fullname: Hartley – volume: 92 start-page: 4 year: 2009 end-page: 14 ident: b0185 article-title: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients publication-title: Radiother Oncol contributor: fullname: Maillard – volume: 373 start-page: 521 year: 2015 end-page: 529 ident: b0160 article-title: Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer publication-title: N Engl J Med contributor: fullname: Kapre – volume: 9 start-page: 293 year: 2019 ident: b0140 article-title: Functional organ preservation surgery in head and neck cancer: Transoral robotic surgery and beyond publication-title: Front Oncol contributor: fullname: Golusiński – volume: 33 start-page: 139 year: 2001 end-page: 144 ident: b0425 article-title: Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients publication-title: Clin Infect Dis contributor: fullname: Dykewicz – volume: 32 start-page: 2735 year: 2014 end-page: 2743 ident: b0290 article-title: Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer publication-title: J Clin Oncol contributor: fullname: Kocherginsky – volume: 36 start-page: 3152 year: 2018 end-page: 3161 ident: b0055 article-title: Human papillomavirus testing in head and neck carcinomas: ASCO Clinical Practice Guideline endorsement of the College of American Pathologists guideline publication-title: J Clin Oncol contributor: fullname: Rooper – volume: 31 start-page: 845 year: 2013 end-page: 852 ident: b0260 article-title: Long-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer publication-title: J Clin Oncol contributor: fullname: Weber – start-page: Jco2000275 year: 2020 ident: b0355 article-title: Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline publication-title: J Clin Oncol contributor: fullname: Alvarez – volume: 32 start-page: 2940 year: 2014 end-page: 2950 ident: b0240 article-title: Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522 publication-title: J Clin Oncol contributor: fullname: Rosenthal – volume: 29 start-page: 1273 year: 2018 end-page: 1279 ident: b0050 article-title: Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing publication-title: Ann Oncol contributor: fullname: van Bokhoven – volume: 134 start-page: 1 year: 2019 end-page: 9 ident: b0110 article-title: Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update publication-title: Radiother Oncol contributor: fullname: Troussier – volume: 28 start-page: 2386 year: 2017 end-page: 2398 ident: b0015 article-title: Human papillomavirus-related oropharyngeal cancer publication-title: Ann Oncol contributor: fullname: Pavón – volume: 91 start-page: 150 year: 2009 end-page: 156 ident: b0175 article-title: GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas publication-title: Radiother Oncol contributor: fullname: Haie-Méder – volume: 88 start-page: 890 year: 1996 end-page: 899 ident: b0265 article-title: Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group publication-title: J Natl Cancer Inst contributor: fullname: Luboinski – volume: 45 start-page: 28 year: 2016 ident: b0350 article-title: The role of transoral robotic surgery, transoral laser microsurgery, and lingual tonsillectomy in the identification of head and neck squamous cell carcinoma of unknown primary origin: a systematic review publication-title: J Otolaryngol Head Neck Surg contributor: fullname: Goldstein – volume: 36 start-page: 3077 year: 2018 end-page: 3083 ident: b0310 article-title: Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: Results of the GORTEC 2007–02 phase III randomized trial publication-title: J Clin Oncol contributor: fullname: De Raucourt – volume: 71 start-page: 9 year: 2020 end-page: 15 ident: b0400 article-title: Risk of onset of second neoplasms and successive neoplasms in patients with a head and neck index tumour publication-title: Acta Otorrinolaringol Esp contributor: fullname: López – volume: 5 start-page: 489 year: 2004 end-page: 500 ident: b0080 article-title: Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression publication-title: Cancer Cell contributor: fullname: Karaca – volume: 9 start-page: 86 year: 2019 ident: b0195 article-title: Low-dose vs. high-dose cisplatin: Lessons learned from 59 chemoradiotherapy trials in head and neck cancer publication-title: Front Oncol contributor: fullname: Kiyota – volume: 350 start-page: 1945 year: 2004 end-page: 1952 ident: b0330 article-title: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer publication-title: N Engl J Med contributor: fullname: Ozsahin – volume: 38 start-page: 628 year: 2016 end-page: 634 ident: b0150 article-title: Analysis of sentinel node biopsy combined with other diagnostic tools in staging cN0 head and neck cancer: a diagnostic meta-analysis publication-title: Head Neck contributor: fullname: Wang – volume: 100 start-page: 22 year: 2011 end-page: 32 ident: b0170 article-title: Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck–a systematic review and meta-analysis publication-title: Radiother Oncol contributor: fullname: Overgaard – volume: 14 start-page: 257 year: 2013 end-page: 264 ident: b0305 article-title: Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial publication-title: Lancet Oncol contributor: fullname: Rabinowits – volume: 87 start-page: 221 year: 2008 end-page: 229 ident: b0030 article-title: Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial publication-title: Radiother Oncol contributor: fullname: Hoekstra – volume: 20 start-page: 1349 year: 2019 end-page: 1359 ident: b0135 article-title: Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial publication-title: Lancet Oncol contributor: fullname: Prisman – volume: 41 start-page: 3700 year: 2019 end-page: 3711 ident: b0060 article-title: Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary publication-title: Head Neck contributor: fullname: Pavlidis – volume: 354 start-page: 567 year: 2006 end-page: 578 ident: b0225 article-title: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck publication-title: N Engl J Med contributor: fullname: Giralt – volume: 18 start-page: 1022 year: 2017 end-page: 1039 ident: b0010 article-title: Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study publication-title: Lancet Oncol contributor: fullname: Botta – volume: 22 start-page: 69 year: 2004 end-page: 76 ident: b0220 article-title: Final results of the 94–01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma publication-title: J Clin Oncol contributor: fullname: Bardet – volume: 29 start-page: iv262 year: 2018 ident: b0415 article-title: Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol contributor: fullname: Mahner – volume: 51 start-page: 571 year: 2001 end-page: 578 ident: b0345 article-title: Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Brown – volume: 37 start-page: 6002 year: 2019 ident: b0375 article-title: TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) publication-title: J Clin Oncol contributor: fullname: Mesia – volume: 67 start-page: 174 year: 2016 end-page: 182 ident: b0200 article-title: Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma publication-title: Eur J Cancer contributor: fullname: Xu – volume: 393 start-page: 40 year: 2019 end-page: 50 ident: b0235 article-title: Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial publication-title: Lancet contributor: fullname: Harris – volume: 357 start-page: 1695 year: 2007 end-page: 1704 ident: b0275 article-title: Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer publication-title: N Engl J Med contributor: fullname: van Herpen – volume: 517 start-page: 576 issue: 7536 year: 2015 ident: 10.1016/j.oraloncology.2020.105042_b0070 article-title: Comprehensive genomic characterization of head and neck squamous cell carcinomas publication-title: Nature doi: 10.1038/nature14129 – volume: 324 start-page: 1685 issue: 24 year: 1991 ident: 10.1016/j.oraloncology.2020.105042_b0270 article-title: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer publication-title: N Engl J Med doi: 10.1056/NEJM199106133242402 contributor: fullname: Wolf – volume: 21 start-page: 870 issue: 4 year: 2015 ident: 10.1016/j.oraloncology.2020.105042_b0085 article-title: Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-2481 contributor: fullname: Keck – volume: 32 start-page: 1 issue: 1 year: 2012 ident: 10.1016/j.oraloncology.2020.105042_b0025 article-title: A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism publication-title: Acta Otorhinolaryngol Ital contributor: fullname: Cadoni – volume: 38 start-page: 628 issue: 4 year: 2016 ident: 10.1016/j.oraloncology.2020.105042_b0150 article-title: Analysis of sentinel node biopsy combined with other diagnostic tools in staging cN0 head and neck cancer: a diagnostic meta-analysis publication-title: Head Neck doi: 10.1002/hed.23945 contributor: fullname: Liao – volume: 28 start-page: 2386 issue: 10 year: 2017 ident: 10.1016/j.oraloncology.2020.105042_b0015 article-title: Human papillomavirus-related oropharyngeal cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdx304 contributor: fullname: Taberna – volume: 6 start-page: 9627 issue: 11 year: 2015 ident: 10.1016/j.oraloncology.2020.105042_b0090 article-title: Head and neck cancer subtypes with biological and clinical relevance: meta-analysis of gene-expression data publication-title: Oncotarget doi: 10.18632/oncotarget.3301 contributor: fullname: De Cecco – volume: 38 start-page: 6502 issue: 15_suppl year: 2020 ident: 10.1016/j.oraloncology.2020.105042_b0340 article-title: Phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck (JCOG1008) publication-title: J Clin Oncol doi: 10.1200/JCO.2020.38.15_suppl.6502 contributor: fullname: Kiyota – volume: 26 start-page: 3582 issue: 21 year: 2008 ident: 10.1016/j.oraloncology.2020.105042_b0255 article-title: Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis publication-title: J Clin Oncol doi: 10.1200/JCO.2007.14.8841 contributor: fullname: Machtay – volume: 359 start-page: 1116 issue: 11 year: 2008 ident: 10.1016/j.oraloncology.2020.105042_b0370 article-title: Platinum-based chemotherapy plus cetuximab in head and neck cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa0802656 contributor: fullname: Vermorken – start-page: 17 year: 2017 ident: 10.1016/j.oraloncology.2020.105042_b0100 article-title: Head and neck tumours contributor: fullname: O'Sullivan – volume: 393 start-page: 40 issue: 10166 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0235 article-title: Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial publication-title: Lancet doi: 10.1016/S0140-6736(18)32779-X contributor: fullname: Gillison – volume: 126 start-page: 3 issue: 1 year: 2018 ident: 10.1016/j.oraloncology.2020.105042_b0120 publication-title: Radiother Oncol doi: 10.1016/j.radonc.2017.10.016 contributor: fullname: Grégoire – volume: 88 start-page: 66 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0125 article-title: Intensity modulated proton therapy (IMPT) - the future of IMRT for head and neck cancer publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2018.11.015 contributor: fullname: Moreno – volume: 100 start-page: 22 issue: 1 year: 2011 ident: 10.1016/j.oraloncology.2020.105042_b0170 article-title: Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck–a systematic review and meta-analysis publication-title: Radiother Oncol doi: 10.1016/j.radonc.2011.03.004 contributor: fullname: Overgaard – volume: 108 issue: 4 year: 2016 ident: 10.1016/j.oraloncology.2020.105042_b0285 article-title: Long-term results of a multicenter randomized phase III trial of induction chemotherapy with cisplatin, 5-fluorouracil, +/- docetaxel for larynx preservation publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djv368 contributor: fullname: Janoray – year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0105 article-title: Prognostic case volume thresholds in patients with head and neck squamous cell carcinoma publication-title: JAMA Otolaryngol Head Neck Surg doi: 10.1001/jamaoto.2019.1187 contributor: fullname: Torabi – volume: 32 start-page: 3858 issue: 34 year: 2014 ident: 10.1016/j.oraloncology.2020.105042_b0205 article-title: Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity publication-title: J Clin Oncol doi: 10.1200/JCO.2014.55.3925 contributor: fullname: Nguyen-Tan – volume: 66 start-page: 10 year: 2017 ident: 10.1016/j.oraloncology.2020.105042_b0045 article-title: The fourth edition of the head and neck World Health Organization blue book: editors' perspectives publication-title: Hum Pathol doi: 10.1016/j.humpath.2017.05.014 contributor: fullname: El-Naggar – volume: 350 start-page: 1945 issue: 19 year: 2004 ident: 10.1016/j.oraloncology.2020.105042_b0330 article-title: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa032641 contributor: fullname: Bernier – volume: 33 start-page: 139 issue: 2 year: 2001 ident: 10.1016/j.oraloncology.2020.105042_b0425 article-title: Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients publication-title: Clin Infect Dis doi: 10.1086/321805 contributor: fullname: Dykewicz – volume: 31 start-page: 543 issue: 5 year: 2013 ident: 10.1016/j.oraloncology.2020.105042_b0250 article-title: Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis publication-title: J Clin Oncol doi: 10.1200/JCO.2012.44.0164 contributor: fullname: O'Sullivan – volume: 28 start-page: 2206 issue: 9 year: 2017 ident: 10.1016/j.oraloncology.2020.105042_b0295 article-title: Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial publication-title: Ann Oncol doi: 10.1093/annonc/mdx299 contributor: fullname: Ghi – volume: 357 start-page: 1695 issue: 17 year: 2007 ident: 10.1016/j.oraloncology.2020.105042_b0275 article-title: Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa071028 contributor: fullname: Vermorken – volume: 98 start-page: 1002 issue: 5 year: 2017 ident: 10.1016/j.oraloncology.2020.105042_b0325 article-title: Final report of a prospective randomized trial to evaluate the dose-response relationship for postoperative radiation therapy and pathologic risk groups in patients with head and neck cancer publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2017.02.218 contributor: fullname: Rosenthal – volume: 121 start-page: 123 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0380 article-title: Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck publication-title: Eur J Cancer doi: 10.1016/j.ejca.2019.08.026 contributor: fullname: Saleh – volume: 14 start-page: 257 issue: 3 year: 2013 ident: 10.1016/j.oraloncology.2020.105042_b0305 article-title: Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(13)70011-1 contributor: fullname: Haddad – volume: 67 start-page: 174 year: 2016 ident: 10.1016/j.oraloncology.2020.105042_b0200 article-title: Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma publication-title: Eur J Cancer doi: 10.1016/j.ejca.2016.08.013 contributor: fullname: Spreafico – volume: 394 start-page: 1915 issue: 10212 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0365 article-title: Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study publication-title: Lancet doi: 10.1016/S0140-6736(19)32591-7 contributor: fullname: Burtness – volume: 36 start-page: 3152 issue: 31 year: 2018 ident: 10.1016/j.oraloncology.2020.105042_b0055 article-title: Human papillomavirus testing in head and neck carcinomas: ASCO Clinical Practice Guideline endorsement of the College of American Pathologists guideline publication-title: J Clin Oncol doi: 10.1200/JCO.18.00684 contributor: fullname: Fakhry – volume: 20 start-page: 1349 issue: 10 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0135 article-title: Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(19)30410-3 contributor: fullname: Nichols – volume: 7 start-page: 184 issue: 1 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0065 article-title: The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) publication-title: J ImmunoTher Cancer doi: 10.1186/s40425-019-0662-5 contributor: fullname: Cohen – volume: 29 start-page: 1273 issue: 5 year: 2018 ident: 10.1016/j.oraloncology.2020.105042_b0050 article-title: Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing publication-title: Ann Oncol doi: 10.1093/annonc/mdy060 contributor: fullname: Nauta – volume: 22 start-page: 4735 issue: 18 year: 2016 ident: 10.1016/j.oraloncology.2020.105042_b0095 article-title: Subtypes of HPV-positive head and neck cancers are associated with HPV characteristics, copy number alterations, PIK3CA mutation, and pathway signatures publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-16-0323 contributor: fullname: Zhang – start-page: Jco2000275 year: 2020 ident: 10.1016/j.oraloncology.2020.105042_b0355 article-title: Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline publication-title: J Clin Oncol contributor: fullname: Maghami – volume: 88 start-page: 890 issue: 13 year: 1996 ident: 10.1016/j.oraloncology.2020.105042_b0265 article-title: Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group publication-title: J Natl Cancer Inst doi: 10.1093/jnci/88.13.890 contributor: fullname: Lefebvre – volume: 55 start-page: 1411 issue: 9 year: 2014 ident: 10.1016/j.oraloncology.2020.105042_b0315 article-title: Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes publication-title: J Nucl Med doi: 10.2967/jnumed.113.136796 contributor: fullname: Marcus – volume: 46 start-page: 285 issue: 2 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0145 article-title: Oncological outcomes of early glottic carcinoma treated with transoral robotic surgery publication-title: Auris Nasus Larynx doi: 10.1016/j.anl.2018.08.015 contributor: fullname: Kayhan – volume: 92 start-page: 4 issue: 1 year: 2009 ident: 10.1016/j.oraloncology.2020.105042_b0185 article-title: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients publication-title: Radiother Oncol doi: 10.1016/j.radonc.2009.04.014 contributor: fullname: Pignon – volume: 112 start-page: 2710 issue: 12 year: 2008 ident: 10.1016/j.oraloncology.2020.105042_b0395 article-title: Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies publication-title: Cancer doi: 10.1002/cncr.23442 contributor: fullname: Vermorken – volume: 26 start-page: 3 issue: 1 year: 1993 ident: 10.1016/j.oraloncology.2020.105042_b0320 article-title: Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/0360-3016(93)90167-T contributor: fullname: Peters – volume: 118 start-page: 238 issue: 2 year: 2016 ident: 10.1016/j.oraloncology.2020.105042_b0245 article-title: Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials publication-title: Radiother Oncol doi: 10.1016/j.radonc.2015.10.014 contributor: fullname: Budach – volume: 68 start-page: 394 issue: 6 year: 2018 ident: 10.1016/j.oraloncology.2020.105042_b0005 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21492 contributor: fullname: Bray – volume: 71 start-page: 9 issue: 1 year: 2020 ident: 10.1016/j.oraloncology.2020.105042_b0400 article-title: Risk of onset of second neoplasms and successive neoplasms in patients with a head and neck index tumour publication-title: Acta Otorrinolaringol Esp doi: 10.1016/j.otorri.2018.11.003 contributor: fullname: León – volume: 86 start-page: 171 year: 2018 ident: 10.1016/j.oraloncology.2020.105042_b0130 article-title: The interplay of IMRT and transoral surgery in HPV-mediated oropharyngeal cancer: getting the balance right publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2018.09.020 contributor: fullname: Huang – volume: 393 start-page: 156 issue: 10167 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0390 article-title: Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study publication-title: Lancet doi: 10.1016/S0140-6736(18)31999-8 contributor: fullname: Cohen – volume: 91 start-page: 150 issue: 2 year: 2009 ident: 10.1016/j.oraloncology.2020.105042_b0175 article-title: GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas publication-title: Radiother Oncol doi: 10.1016/j.radonc.2009.01.005 contributor: fullname: Mazeron – volume: 32 start-page: 2940 issue: 27 year: 2014 ident: 10.1016/j.oraloncology.2020.105042_b0240 article-title: Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522 publication-title: J Clin Oncol doi: 10.1200/JCO.2013.53.5633 contributor: fullname: Ang – volume: 18 start-page: 79 issue: 2 year: 2010 ident: 10.1016/j.oraloncology.2020.105042_b0180 article-title: The role of the head and neck surgeon in contemporary multidisciplinary treatment programs for advanced head and neck cancer publication-title: Curr Opin Otolaryngol Head Neck Surg doi: 10.1097/MOO.0b013e32833782f0 contributor: fullname: Wong – volume: 3 start-page: 1487 issue: 11 year: 2017 ident: 10.1016/j.oraloncology.2020.105042_b0360 article-title: Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2017.0973 contributor: fullname: Leeman – volume: 25 start-page: 216 issue: 1 year: 2014 ident: 10.1016/j.oraloncology.2020.105042_b0300 article-title: A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdt461 contributor: fullname: Hitt – volume: 24 start-page: 190 issue: 3 year: 2012 ident: 10.1016/j.oraloncology.2020.105042_b0035 article-title: 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers–an audit and review of published studies publication-title: Clin Oncol (R Coll Radiol) doi: 10.1016/j.clon.2011.11.001 contributor: fullname: Wong – volume: 134 start-page: 1 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0110 article-title: Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update publication-title: Radiother Oncol doi: 10.1016/j.radonc.2019.01.018 contributor: fullname: Biau – volume: 18 start-page: 1221 issue: 9 year: 2017 ident: 10.1016/j.oraloncology.2020.105042_b0165 article-title: Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis publication-title: Lancet Oncol doi: 10.1016/S1470-2045(17)30458-8 contributor: fullname: Lacas – volume: 357 start-page: 1705 issue: 17 year: 2007 ident: 10.1016/j.oraloncology.2020.105042_b0280 article-title: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa070956 contributor: fullname: Posner – volume: 5 start-page: 489 issue: 5 year: 2004 ident: 10.1016/j.oraloncology.2020.105042_b0080 article-title: Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression publication-title: Cancer Cell doi: 10.1016/S1535-6108(04)00112-6 contributor: fullname: Chung – volume: 110 start-page: 172 issue: 1 year: 2014 ident: 10.1016/j.oraloncology.2020.105042_b0115 article-title: Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines publication-title: Radiother Oncol doi: 10.1016/j.radonc.2013.10.010 contributor: fullname: Grégoire – volume: 41 start-page: 3700 issue: 10 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0060 article-title: Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary publication-title: Head Neck doi: 10.1002/hed.25858 contributor: fullname: Rassy – volume: 161 start-page: 635 issue: 4 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0405 article-title: Surveillance of patients with head and neck cancer with an intensive clinical and radiologic follow-up publication-title: Otolaryngol Head Neck Surg doi: 10.1177/0194599819860808 contributor: fullname: Imbimbo – volume: 354 start-page: 567 issue: 6 year: 2006 ident: 10.1016/j.oraloncology.2020.105042_b0225 article-title: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck publication-title: N Engl J Med doi: 10.1056/NEJMoa053422 contributor: fullname: Bonner – volume: 37 start-page: 6002 issue: 15_suppl year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0375 article-title: TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) publication-title: J Clin Oncol doi: 10.1200/JCO.2019.37.15_suppl.6002 contributor: fullname: Guigay – volume: 45 start-page: 28 issue: 1 year: 2016 ident: 10.1016/j.oraloncology.2020.105042_b0350 article-title: The role of transoral robotic surgery, transoral laser microsurgery, and lingual tonsillectomy in the identification of head and neck squamous cell carcinoma of unknown primary origin: a systematic review publication-title: J Otolaryngol Head Neck Surg doi: 10.1186/s40463-016-0142-6 contributor: fullname: Fu – volume: 28 start-page: 2340 issue: 10 year: 2017 ident: 10.1016/j.oraloncology.2020.105042_b0420 article-title: ESMO-Magnitude of Clinical Benefit Scale version 1.1 publication-title: Ann Oncol doi: 10.1093/annonc/mdx310 contributor: fullname: Cherny – volume: 51 start-page: 2777 issue: 18 year: 2015 ident: 10.1016/j.oraloncology.2020.105042_b0155 article-title: Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer publication-title: Eur J Cancer doi: 10.1016/j.ejca.2015.08.023 contributor: fullname: Schilling – volume: 51 start-page: 571 issue: 3 year: 2001 ident: 10.1016/j.oraloncology.2020.105042_b0345 article-title: Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(01)01690-X contributor: fullname: Ang – volume: 18 start-page: 1022 issue: 8 year: 2017 ident: 10.1016/j.oraloncology.2020.105042_b0010 article-title: Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study publication-title: Lancet Oncol doi: 10.1016/S1470-2045(17)30445-X contributor: fullname: Gatta – volume: 87 start-page: 221 issue: 2 year: 2008 ident: 10.1016/j.oraloncology.2020.105042_b0030 article-title: Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial publication-title: Radiother Oncol doi: 10.1016/j.radonc.2008.03.008 contributor: fullname: Senft – volume: 18 start-page: 269 issue: 5 year: 2018 ident: 10.1016/j.oraloncology.2020.105042_b0075 article-title: The molecular landscape of head and neck cancer publication-title: Nat Rev Cancer doi: 10.1038/nrc.2018.11 contributor: fullname: Leemans – volume: 350 start-page: 1937 issue: 19 year: 2004 ident: 10.1016/j.oraloncology.2020.105042_b0335 article-title: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck publication-title: N Engl J Med doi: 10.1056/NEJMoa032646 contributor: fullname: Cooper – volume: 373 start-page: 521 issue: 6 year: 2015 ident: 10.1016/j.oraloncology.2020.105042_b0160 article-title: Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1506007 contributor: fullname: D'Cruz – volume: 32 start-page: 2735 issue: 25 year: 2014 ident: 10.1016/j.oraloncology.2020.105042_b0290 article-title: Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2013.54.6309 contributor: fullname: Cohen – volume: 28 start-page: iv1 issue: suppl_4 year: 2017 ident: 10.1016/j.oraloncology.2020.105042_b0410 article-title: Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol doi: 10.1093/annonc/mdx222 contributor: fullname: Postmus – volume: 100 start-page: 33 issue: 1 year: 2011 ident: 10.1016/j.oraloncology.2020.105042_b0190 article-title: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site publication-title: Radiother Oncol doi: 10.1016/j.radonc.2011.05.036 contributor: fullname: Blanchard – volume: 13 start-page: 145 issue: 2 year: 2012 ident: 10.1016/j.oraloncology.2020.105042_b0215 article-title: Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99–02): an open-label phase 3 randomised trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(11)70346-1 contributor: fullname: Bourhis – volume: 29 start-page: iv262 issue: Suppl 4 year: 2018 ident: 10.1016/j.oraloncology.2020.105042_b0415 article-title: Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol doi: 10.1093/annonc/mdy160 contributor: fullname: Marth – volume: 22 start-page: 69 issue: 1 year: 2004 ident: 10.1016/j.oraloncology.2020.105042_b0220 article-title: Final results of the 94–01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma publication-title: J Clin Oncol doi: 10.1200/JCO.2004.08.021 contributor: fullname: Denis – volume: 375 start-page: 1856 issue: 19 year: 2016 ident: 10.1016/j.oraloncology.2020.105042_b0385 article-title: Nivolumab for recurrent squamous-cell carcinoma of the head and neck publication-title: N Engl J Med doi: 10.1056/NEJMoa1602252 contributor: fullname: Ferris – volume: 374 start-page: 1444 issue: 15 year: 2016 ident: 10.1016/j.oraloncology.2020.105042_b0040 article-title: PET-CT surveillance versus neck dissection in advanced head and neck cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1514493 contributor: fullname: Mehanna – volume: 36 start-page: 3077 issue: 31 year: 2018 ident: 10.1016/j.oraloncology.2020.105042_b0310 article-title: Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: Results of the GORTEC 2007–02 phase III randomized trial publication-title: J Clin Oncol doi: 10.1200/JCO.2017.76.2591 contributor: fullname: Geoffrois – volume: 9 start-page: 293 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0140 article-title: Functional organ preservation surgery in head and neck cancer: Transoral robotic surgery and beyond publication-title: Front Oncol doi: 10.3389/fonc.2019.00293 contributor: fullname: Golusiński – volume: 363 start-page: 24 issue: 1 year: 2010 ident: 10.1016/j.oraloncology.2020.105042_b0020 article-title: Human papillomavirus and survival of patients with oropharyngeal cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa0912217 contributor: fullname: Ang – volume: 9 start-page: 86 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0195 article-title: Low-dose vs. high-dose cisplatin: Lessons learned from 59 chemoradiotherapy trials in head and neck cancer publication-title: Front Oncol doi: 10.3389/fonc.2019.00086 contributor: fullname: Szturz – volume: 36 start-page: 1064 issue: 11 year: 2018 ident: 10.1016/j.oraloncology.2020.105042_b0210 article-title: Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: A phase III randomized noninferiority trial publication-title: J Clin Oncol doi: 10.1200/JCO.2017.74.9457 contributor: fullname: Noronha – volume: 393 start-page: 51 issue: 10166 year: 2019 ident: 10.1016/j.oraloncology.2020.105042_b0230 article-title: Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial publication-title: Lancet doi: 10.1016/S0140-6736(18)32752-1 contributor: fullname: Mehanna – volume: 31 start-page: 845 issue: 7 year: 2013 ident: 10.1016/j.oraloncology.2020.105042_b0260 article-title: Long-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2012.43.6097 contributor: fullname: Forastiere |
| SSID | ssj0005150 |
| Score | 2.4299824 |
| Snippet | •This EHNS-ESMO-ESTRO Clinical Practice Guideline provides key recommendations for managing SCCHN.•It covers clinical and pathological diagnosis, staging and... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 105042 |
| SubjectTerms | Clinical Practice Guidelines Diagnosis Follow-up SCCHN Treatment |
| Title | Reprint of “Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up” |
| URI | https://dx.doi.org/10.1016/j.oraloncology.2020.105042 https://www.ncbi.nlm.nih.gov/pubmed/33583513 https://search.proquest.com/docview/2489600140 |
| Volume | 113 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB61Wwl6QaX8dPmpjMRxwyaO7cRIHKqyZQHtFrGt1FvkOLG6CJJQdgV7QX0Q-hY8UZ-EmfwUOFRC4hIljpxYmbHnm_ibGYCneWa5n0rricg4PITWS43Snm-tdrnWMsopUHgyVeNj8eZEnqzBfhcLQ7TKdu1v1vR6tW5bhu3XHFbz-XAWhCpG90py2t2LYrEOG2iOhOjBxt7rt-Ppb6ZHIJtgYRV71KHLPVrTvCgOvizqDNErdBd5XfnWF_w6O3UdDq3t0cEW3GqBJNtrxnob1vJiG26-JPIP1W_bhhuTdtv8DvxEmH02LxasdOzy_Mfs89KQx8_orz2zVE2oKD8ZuotwkNFYsZWKSgwYOr6r4tsAG8vqtD5npsjY6arqrp-z0Xg680azySEejt4fsjbX6Ef2rg3BYq-WlE2LGPYMQTLLGn7f_MuAXRHd68c61Mryq7esLs8v7sLxwehof-y15Ro8y7VceEGUZk6bWJmMYI10ghsTKZr0NjA6lpnOAj-XNlTKOo6w3unAUTYbh7hDpuE96BVlke8AEyqViEMsIv9ARGmsnR9SpkOZWS1EqvoQdsJJqiYrR9LR1T4kf4o0IZEmjUj78KKTY_KXjiVoPv6p_5NO-AlOQpKRKXIUV8JFrFWdqqgP9xutuBpXGEpEuUH44D_f_hA2OfFpasb4I-gtzpb5YwREi3QX1p99D3Zbtf8Fxg4PGg |
| link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFLXKVKJsUCmvgQJGYjnRJI7txEhdVGVKSjtTxEyl7izHidVBkIQyI5hdP6T8BV_UL-HePAosKiGxiRJHTqwcP86Nz72XkFd5ZpmfCuvxyDg4hNZLjVSeb61yuVIiytFReDyRyQl_dypO18he5wuDssp27m_m9Hq2bkuG7dccVvP5cBqEMgbzSjDc3YtifouscxEFrEfWdw8Ok8lvpUcgGmdhGXtYoYs9Wsu80A--LOoI0SswF1md-dbn7KZ16iYeWq9H-5vkbksk6W7T1ntkLS-2yMYbFP9g_rYtcnvcbpvfJz-BZp_PiwUtHb26uJx-WRq0-Cn-tacWswkV5WeDd4EOUmwrlGJSiQEFw3dVfB9AYVmd1efUFBk9W1Xd9Ws6SiZTbzQdH8Nh9uGYtrFGP9H3rQsWfbvEaFqosKdAkmnW6PvmXwf0WuheP9ZBryy_ecvq6uLHA3KyP5rtJV6brsGzTImFF0Rp5pSJpcmQ1gjHmTGRxEFvA6Nikaks8HNhQymtY0DrnQocRrNxwDtEGj4kvaIs8seEcpkK4CEWmH_AozRWzg8x0qHIrOI8lX0SduDoqonKoTu52kf9J6QaIdUNpH2y0-Go_-pjGpaPf6r_sgNfwyBEjEyRA1ya8VjJOlRRnzxqesV1u8JQAMsNwif_-fYXZCOZjY_00cHk8Cm5w1BbU6vHt0lvcb7MnwE5WqTP287_C0YYEQo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reprint+of+%E2%80%9CSquamous+cell+carcinoma+of+the+oral+cavity%2C+larynx%2C+oropharynx+and+hypopharynx%3A+EHNS-ESMO-ESTRO+Clinical+Practice+Guidelines+for+diagnosis%2C+treatment+and+follow-up%E2%80%9D&rft.jtitle=Oral+oncology&rft.au=Machiels%2C+J.-P.&rft.au=Ren%C3%A9+Leemans%2C+C.&rft.au=Golusinski%2C+W.&rft.au=Grau%2C+C.&rft.date=2021-02-01&rft.issn=1368-8375&rft.volume=113&rft.spage=105042&rft_id=info:doi/10.1016%2Fj.oraloncology.2020.105042&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_oraloncology_2020_105042 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1368-8375&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1368-8375&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1368-8375&client=summon |